TherapeuticsMD (TXMD) Cash from Investing Activities (QoQ) (2011 - 2022)
TherapeuticsMD (TXMD) Cash from Investing Activities (QoQ) (2011 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | TherapeuticsMD | 280,418.39 | -8.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1,157.14% |
| Sep 30, 2022 | 109.21% |
| Jun 30, 2022 | 64.15% |
| Mar 31, 2022 | 86.00% |
| Dec 31, 2021 | -731.87% |
| Sep 30, 2021 | -104.49% |
| Jun 30, 2021 | 79.68% |
| Mar 31, 2021 | 11.34% |
| Dec 31, 2020 | -88.55% |
| Sep 30, 2020 | 34.34% |
| Jun 30, 2020 | 9.93% |
| Mar 31, 2020 | 97.86% |
| Dec 31, 2019 | -1,490.66% |
| Sep 30, 2019 | -7.60% |
| Jun 30, 2019 | -81.74% |
| Mar 31, 2019 | 0.78% |
| Dec 31, 2018 | 96.70% |
| Sep 30, 2018 | -6,431.11% |
| Jun 30, 2018 | -72.47% |
| Mar 31, 2018 | 48.64% |